FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 167 filers reported holding FATE THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18 | -40.0% | 4 | 0.0% | 0.00% | – |
| Q1 2024 | $30 | +100.0% | 4 | 0.0% | 0.00% | – |
| Q4 2023 | $15 | +66.7% | 4 | 0.0% | 0.00% | – |
| Q3 2023 | $9 | -98.7% | 4 | -97.3% | 0.00% | – |
| Q2 2023 | $700 | +115.4% | 147 | +157.9% | 0.00% | – |
| Q1 2023 | $325 | -67.5% | 57 | +90.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 30 | +130.8% | 0.00% | – |
| Q2 2022 | $0 | – | 13 | +116.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 6 | -96.2% | 0.00% | – |
| Q3 2021 | $9,000 | – | 156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
| Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
| Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
| Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
| Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
| Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
| Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
| Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
| Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |